Mitsubishi Tanabe recalls drugs

TOKYO, Japan - Mitsubishi Tanabe Pharma Corp. President Michihiro Tsuchiya (2nd from L) bows in apology during a press conference in Tokyo on Jan. 26, 2011. The drugmaker initiated a voluntary recall of three injection solution products that one of its subsidiaries may have shipped without conducting quality tests. (Kyodo)

Sample
PDF Preview

Product Code
ILEA000331524

Registered date
2011/1/26 00:00:00

Credit
Kyodo / Kyodo News Images

Media source

Media size
1320 × 1303 pixel

Resolution
240 dpi

Deployment size
399.69(KB)*

Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos

Toyota's improper vehicle testing

Toyota Motor Corp. Chairman Akio Toyoda bows in apology during a press conference in Tokyo on June 3, 2024, after the company improperly obtained vehicle certifications for seven models of car by conducting safety tests in ways not specified by the government.

CORRECTED: Mazda Motor's improper vehicle testing

Mazda Motor Corp. President Masahiro Moro bows in apology after the company improperly obtained vehicle certifications for five car models by conducting safety tests in ways not specified by the government during a press conference in Tokyo on June 3, 2024.

Panel concludes Mizuho's poor system operation caused ATM failures

Mizuho Financial Group Inc. CEO Tatsufumi Sakai (2nd from L) and Mizuho Bank President Koji Fujiwara (3rd from L) bow in apology at a press conference in Tokyo on June 15, 2021. A third-party panel concluded the same day that a series of system failures that hit the Japanese megabank earlier this year, including many of its automated teller machines, were due to poor operation and management rather than system defects.

Sharp admits sales padded at subsidiary

Sharp Corp. President Katsuaki Nomura bows in apology at a press conference in Sakai, Osaka, on March 12, 2021. He said Kantatsu Co., one of its subsidiaries, had padded its sales by around 7.5 billion yen ($69 million) through fraudulent accounting.

Tokyo stock trading stops due to system glitch

Koichiro Miyahara (2nd from L), president and CEO of the Tokyo Stock Exchange, bows in apology at a press conference in Tokyo on Oct. 1, 2020, after a system glitch caused a suspension of the day's trading.

Kansai Electric President Takashi Morimoto

Kansai Electric Power Co. President Takashi Morimoto (2nd from L) speaks at a press conference following a shareholder meeting in Osaka on June 25, 2020. The company appointed Sadayuki Sakakibara, a former head of the Japan Business Federation, as its new chairman to regain public trust following a scandal in which a former deputy mayor of a town hosting one of its nuclear plants was found to have bribed company executives. (Kyodo) ==Kyodo

Press conference on the identification of existing drugs in Japan

The photo shows Professor Junichiro Inoue of the Institute of Medical Science, University of Tokyo taking off his mask for explanation. (March 18, 2020, Yasuda Auditorium, University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)

Press conference on the identification of existing drugs in Japan

Photo shows Yuji Yamanashi, Director of the Institute of Medical Science, University of Tokyo, at a press conference. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)

Press conference on the identification of existing drugs in Japan

Photo shows Professor Junichiro Inoue of the Institute of Medical Science, University of Tokyo, at a press conference. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)